Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study-Reference-Cited by-同舟云学术

Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study

Published:2021-05-01 Issue:3 Volume:68 Page:259-263
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Ban Hiromitsu¹²,Inatomi Osamu¹,Murata Masaki¹,Otsuka Taketo¹,Oi Masayuki¹,Matsumoto Hiroshi¹,Bamba Shigeki¹,Andoh Akira¹

Affiliation:

1. Department of Medicine, Shiga University of Medical Science

2. Department of Gastroenterology, Kusatsu General Hospital

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/68/3/68_20-143/_pdf

Reference26 articles.

1. 1 Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc 2016; 28: 3–15.

2. 2 Tate DJ, Klein A, Sidhu M, et al. Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video). Gastrointest Endosc 2019; 90: 467–479.e4.

3. 3 Otsuka T, Sugimoto M, Ban H, et al. Severity of gastric mucosal atrophy affects the healing speed of post-endoscopic submucosal dissection ulcers. World J Gastrointest Endosc 2018; 10: 83–92.

4. 4 Yoshizawa Y, Sugimoto M, Sato Y, et al. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: multicenter randomized trial. Dig Endosc 2016; 28: 162–172.

5. 5 Wang J, Wu Q, Yan Y, et al. Effectiveness of fibrin sealant as hemostatic technique in accelerating ESD-induced ulcer healing: a retrospective study. Surg Endosc 2020; 34: 1191–1199.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails;Frontiers in Nutrition;2024-09-05

2. Efficacy and Safety of Potassium-Competitive Acid Blockers vs Proton Pump Inhibitors for Peptic Ulcer Disease or Postprocedural Artificial Ulcers: A Systematic Review and Meta-analysis;Clinical and Translational Gastroenterology;2024-07-29

3. Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric endoscopic submucosal dissection-induced ulcer: an updated systematic review and meta-analysis;BMC Gastroenterology;2024-03-15

4. Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study;Journal of Gastroenterology;2023-02-13

5. Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis;World Journal of Clinical Cases;2022-12-16